Aeterna Zentaris
AEZS
#10556
Rank
S$22.67 M
Marketcap
S$7.41
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): S-$2.77

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is S-$2.65. In 2022 the company made an earnings per share (EPS) of S-$6.06 a decrease over its 2021 EPS that were of S-$2.36.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)S-$2.77
2022S-$6.06157.14%
2021S-$2.36-41.48%
2020S-$4.03-64.46%
2019S-$11.33-240%
2018S$8.09-122.32%
2017S-$36.26-53.53%
2016S-$78.01-86.71%
2015S-$587.21-35.21%
2014S-$906.39-216.67%
2013S$776.91-123.3%
2012S-$3,334-40.8%
2011S-$5,633-6.45%
2010S-$6,021-27.91%
2009S-$8,352-61.61%
2008S-$21,75383.61%
2007S-$11,848-195.31%
2006S$12,431178.26%
2005S$4,467-330%
2004S-$1,942-80.05%
2003S-$9,73617.78%
2002S-$8,266515.93%
2001S-$1,342-68.6%
2000S-$4,274119.62%
1999S-$1,946-3.63%
1998S-$2,020

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
S$9.09-442.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$3.31-224.93%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$4.61-273.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
S-$0.47-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
S$3.38-227.38%๐Ÿ‡บ๐Ÿ‡ธ USA